[Form 4] MILESTONE SCIENTIFIC INC. Insider Trading Activity

Rhea-AI Filing Summary

BP4 S.r.l., a director-level reporting person, reported the sale of a total of 19,210 shares of MILESTONE SCIENTIFIC INC. (MLSS) on 10/03/2025 at prices of $0.4491 and $0.45. After these disposals the reporting person beneficially owned 9,235,384 shares. No derivative transactions are reported and the Form 4 is signed by the liquidator on 10/08/2025.

Positive

• Remaining beneficial ownership stays substantial at 9,235,384 shares
• No derivative positions were reported in Table II

Negative

• Disposal of 19,210 shares executed on 10/03/2025 at approx. $0.45
• Reported sales reduced direct holdings from 9,254,594 to 9,235,384 shares

Insights

Insider Transactions Analyst

Small-volume insider sale reduced holdings to 9.24M shares.

The report discloses two open-market sales totaling 19,210 common shares executed on 10/03/2025 at prices near $0.45. The filings show the sales were non-derivative and the remaining beneficial ownership is reported as 9,235,384 shares.

Such filings document ownership changes but do not state motive or plan details. Monitor subsequent Form 4s for additional transactions within the next 30–90 days to see if this is an isolated reduction or part of a pattern.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BP4 S.r.l.

(Last) (First) (Middle)

CORSO VENEZIA 44

(Street)

MILAN L6 20121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MILESTONE SCIENTIFIC INC. [ MLSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $0.001	10/03/2025		S		9,210	D	$0.4491	9,245,384	D
Common Stock, Par Value $0.001	10/03/2025		S		10,000	D	$0.45	9,235,384	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Dr. Pedro Palau, Liquidator	10/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BP4 S.r.l. report on the MLSS Form 4?

BP4 S.r.l. reported two sales totaling 19,210 MLSS shares on 10/03/2025 at prices of $0.4491 and $0.45.

How many MLSS shares does the reporting person own after the transaction?

The reporting person beneficially owned 9,235,384 shares following the reported transactions.

Were any derivative securities reported by the reporting person?

No. Table II shows no derivative securities acquired, disposed of, or beneficially owned.

When was the Form 4 signed?

The Form 4 was signed by Dr. Pedro Palau, Liquidator on 10/08/2025.

What transaction codes were used on the Form 4?

The transactions are reported with code S indicating sale of common stock; an additional code V appears as a filing annotation.